Trials / Completed
CompletedNCT05435573
Cardiac Output in Preeclamptic
Coload Effect on Cardiac Output Measurement Using Transthoracic Echocardiography in Preeclamptic Patients Undergoing Cesarean Delivery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Mansoura University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
There is high incidence of hypertensive disorders during pregnancy.The maternal cardiovascular system had significant changes during pregnancy. The colloid oncotic pressure is decreased during preeclampsia.
Detailed description
Transthoracic echocardiography considered an accurate non-invasive device and has validity for measuring cardiac functions in pregnancy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 1000 mL of ringer's acetate solution | 1000 mL of ringer's acetate solution |
| DRUG | 250 mL 6% hydroxyethyl starch (Voluven) then 500 mL of ringer's acetate solution then 250 mL of 6% hydroxyethyl starch (Voluven) | 500 mL 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride plus 500 mL of ringer's acetate solution |
Timeline
- Start date
- 2022-08-17
- Primary completion
- 2023-09-15
- Completion
- 2024-06-03
- First posted
- 2022-06-28
- Last updated
- 2026-02-17
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05435573. Inclusion in this directory is not an endorsement.